ARCHIVES

Bailer NEJM “Irresponsible, Purposely Misleading,” Ignored Facts, DeVita Tells NCA

This article is from The Cancer Letter archive.

Vol. 12 No. 21 | May 23, 1986

Download PDF Visit The Full Archive

Related Articles

New Biomarker Findings Show Improvement in KRAS Subtype In Phase III Erbitux Trial

May 30, 2014

FDA Oncologic Drug Committee Agrees That “Kitty Fight” With NCI Should Be Negotiated

November 28, 1975

NCI CTEP Approved Trials For the Month of December

December 27, 2013

Golde To Step Down At MSK; Porter Joins Hogan & Hartson.

January 26, 2001

Highlights of Dingell Hearing: Statements Of Visco, Testimony By Broder On Fisher, Uterine Cancer Deaths

April 22, 1994

Drugs and Targets: Akynzeo approved for chemotherapy-related nausea

October 10, 2014